Logo

GE Healthcare's IVD Collaboration With Lilly Tops Most-Read GenomeWeb Daily News Stories Last Week

Oct 08, 2007
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Oct. 5.
 
1. GE Healthcare, Lilly to Co-develop IVDs to Predict Efficacy of Cancer Drugs (from Oct. 1)
 
2. NIH Releases Genetic and Clinical Data from 60-year Framingham Heart Study (from Oct. 2)
 
3. Perlegen, 454 Partner in Drug Response Re-sequencing Study (from Oct. 2)
 
4. USC's Keck School Lands $10M Gift for Epigenomics Center (from Oct. 3)
 
5. Helicos Shuffles Execs; Roche Taps New Dx Head; CuraGen Promotes Finigan; and Others (from Oct. 5)
Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.